French mobile neurosurgical unit: a retrospective analysis of 22 years of mission.

AVIATION MEDICINE NEUROSURGERY Trauma management

Journal

BMJ military health
ISSN: 2633-3775
Titre abrégé: BMJ Mil Health
Pays: England
ID NLM: 101761581

Informations de publication

Date de publication:
20 Jun 2024
Historique:
received: 22 10 2023
accepted: 22 05 2024
medline: 21 6 2024
pubmed: 21 6 2024
entrez: 20 6 2024
Statut: aheadofprint

Résumé

The French mobile neurosurgical unit (MNSU) is used to provide specific support to remote military medicosurgical units deployed in foreign theatres. If a neurosurgical casualty is present, the Role 2 team may request the MNSU to be deployed directly from France. The deployed neurosurgeon can then perform surgery in Role 2 or decide to evacuate the casualty and perform surgery in Role 4 in France. We provide an epidemiological analysis of MNSU missions between 2001 and 2023 and investigate the value of the MNSU for the French Armed Forces. We conducted a retrospective case series that included patients managed by the MNSU from 1 January 2001 to 31 January 2023. We collected epidemiological data (eg, age, military or civilian status, delay between transmission and takeoff, origin of the injury and mission location), clinical records (aetiologies of the injury and disease), data on surgical intervention (operator nature and type of surgery) and data on postoperative outcomes recorded at the time of discharge from hospital. 51 patients were managed by the MNSU. 36 (70.5%) and 3 (5.8%) patients underwent surgery on Role 2 and Role 4, respectively. 39 (76.9%) interventions were due to traumatic injury, 4 (7.8%) due to hydrocephalus, 4 (7.8%) due to vascular causes, 3 (5.9%) due to tumour and 1 (2%) due to spine degeneration. In 30 (76.9%) of these cases, the first operator was a neurosurgeon from the MNSU, whereas in the remaining 9 (23.1%) cases, procedures were initially performed by a non-neurosurgeon. The MNSU contribution to D1 casualties' strategic evacuation (STRATEVAC) is important. The MNSU provides additional support for STRATEVAC during the reorganisation of French Armed Forces engaged in several fronts. With the return of high-intensity wars, the French MNSU must develop and adjust for the management of massive influxes of casualties.

Identifiants

pubmed: 38901975
pii: military-2023-002601
doi: 10.1136/military-2023-002601
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Rayan Fawaz (R)

Neurosurgery, Percy Military Training Hospital, Clamart, France ryfawaz@gmail.com.

F L Maison (FL)

Neurosurgery, Percy Military Training Hospital, Clamart, France.

P Robert (P)

Neurosurgery, Percy Military Training Hospital, Clamart, France.

M Fouet (M)

Neurosurgery, Percy Military Training Hospital, Clamart, France.

J-M Delmas (JM)

Neurosurgery, Percy Military Training Hospital, Clamart, France.

R Dulou (R)

Ecole du Val-de-Grace, Paris, France.

N Desse (N)

Neurosurgery, Percy Military Training Hospital, Clamart, France.

A Dagain (A)

Ecole du Val-de-Grace, Paris, France.
Department of Neurosurgery, Military Teaching Hospital Sainte Anne, Toulon Armees, France.

Classifications MeSH